CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.

Saved in:
Bibliographic Details
Title: CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
Authors: Kouzeli A; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom., Collins PJ; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Metzemaekers M; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Meyrath M; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Szpakowska M; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Artinger M; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland., Struyf S; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Proost P; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Chevigne A; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Legler DF; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland., Eberl M; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom., Moser B; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2020 Oct 05; Vol. 11, pp. 561404. Date of Electronic Publication: 2020 Oct 05 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33123134
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kouzeli+A%22">Kouzeli A</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Collins+PJ%22">Collins PJ</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Metzemaekers+M%22">Metzemaekers M</searchLink>; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Meyrath+M%22">Meyrath M</searchLink>; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Szpakowska+M%22">Szpakowska M</searchLink>; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Artinger+M%22">Artinger M</searchLink>; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Struyf+S%22">Struyf S</searchLink>; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Proost+P%22">Proost P</searchLink>; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Chevigne+A%22">Chevigne A</searchLink>; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Legler+DF%22">Legler DF</searchLink>; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Eberl+M%22">Eberl M</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moser+B%22">Moser B</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2020 Oct 05; Vol. 11, pp. 561404. <i>Date of Electronic Publication: </i>2020 Oct 05 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33123134
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2020.561404
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 561404
    Titles:
      – TitleFull: CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kouzeli A
      – PersonEntity:
          Name:
            NameFull: Collins PJ
      – PersonEntity:
          Name:
            NameFull: Metzemaekers M
      – PersonEntity:
          Name:
            NameFull: Meyrath M
      – PersonEntity:
          Name:
            NameFull: Szpakowska M
      – PersonEntity:
          Name:
            NameFull: Artinger M
      – PersonEntity:
          Name:
            NameFull: Struyf S
      – PersonEntity:
          Name:
            NameFull: Proost P
      – PersonEntity:
          Name:
            NameFull: Chevigne A
      – PersonEntity:
          Name:
            NameFull: Legler DF
      – PersonEntity:
          Name:
            NameFull: Eberl M
      – PersonEntity:
          Name:
            NameFull: Moser B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 10
              Text: 2020 Oct 05
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1